Scale X Formula

Screen: no_websiteContacts: To Do

Description

Scale X Formula is a commercial operating partner firm specializing in revenue transformation for private equity–backed and growth-stage B2B SaaS and technology companies. We embed directly with founders, boards, and PE sponsors to install the commercial structure, forecasting discipline, and operating cadence required to create predictable, scalable growth. We are operators, not consultants. Our work focuses on execution inside the business — rebuilding teams, systems, and accountability — not producing strategy decks. Core Mandates • Commercial turnarounds • Post-acquisition integrations • Revenue organization rebuilds • Forecasting and RevOps discipline • Go-to-market resets • Exit and capital-raise readiness Typical Results • 2×–3× revenue growth in core lines • 60%+ reduction in sales cycles • 5× increase in qualified pipeline • Board-grade forecasting and visibility • Repeatable, scalable revenue engines Who We Work With • Private equity portfolio companies • Growth-stage SaaS businesses ($10M–$150M revenue) • Founder-led companies preparing to scale or exit • Leadership teams navigating post-M&A change Operating Footprint Fully deployable across North America and Europe. Dual US + EU citizenship enables frictionless leadership placement across international markets. For commercial operating partnerships or CRO/CCO mandates, connect directly with Mark Mele, Founder & Operating Partner.

Location

Miami, Florida, United States

Industry

Venture Capital and Private Equity Principals

Investor Type

Target Sectors

Verticals

No verticals classified

Specialities

Revenue Operations, Commercial Turnarounds, PE Portfolio Value Creation, GTM Strategy, Sales Organization Build, Forecasting & Pipeline Discipline, Post-M&A Integration, Embedded CRO / CCO Leadership

Classify Status

Prospects

0 people

No prospects linked to this account.

Outreach History

Outreach sequencing tables are not yet in Supabase.

ID: 2253Airtable: recGxCJO6XLywPMf1Created: 10/04/2026